Topic: Cristian Vallejos

On December 6, 2013, the Food and Drug Administration (FDA) approved the eagerly awaited Hepatitis C medication sofosbuvir (Sovaldi™, Gilead Sciences, Inc.) and gave it the designation of “breakthrough therapy”. An…

Addition to Group Expands Resources for Oregon Clinic Patients in Western Metropolitan Portland The Oregon Clinic, one of Oregon’s largest independent specialty physician practices, is pleased to announce the addition…